This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
VIA AILooking for an interpreter?
Remoto by ProZ.com connects you with an identity-verified interpreter by video or phone in about 60 seconds — 300+ languages, on demand or booked ahead.
Try Remoto »
加入会员日期： Jan '11
工作语言：
Chinese汉语译成English英语 English英语译成Chinese汉语
Client-vendor relationship recorded successfully!
Edward Liu has been added to your list of hired vendors.
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
附属机构
This person is not affiliated with any business or Blue Board record at ProZ.com.
Access to Blue Board comments is restricted for non-members. Click the outsourcer name to view the Blue Board record and see options for gaining access to this information.
原文文本 - English英语 Global Equity Markets Performance
• U.S. stocks advanced last Friday, trimming the weekly loss in the S&P 500, as gains in fuel, metal and industrial companies helped the market overcome a global slump. The S&P 500 declined by 1.3% last week
• Oil surged above $105 last week as Libyan leader Qaddafi’s forces drove rebels from the Mediterranean oil hub of Ras Lanuf and his son pledged to mount a full-scale attack against the uprising
• US economic data were mixed. First-time unemployment benefits rose by 26,000 to 397,000 in the week ended March 5. Retail sales increased in February by the most in four months as Americans took advantage of more seasonable weather to buy cars, clothes and electronics
• With the exception of Greece, National benchmark indexes fell in all of the 18 western European markets on Friday. Greece’s ASE Index climbed 2.3% as European Union leaders gathered in Brussels to discuss a blueprint to improve competitiveness, a plan Germany demanded as a condition for expanding support for the region’s weakest economies
Hong Kong / China Equity Market Performance
• Asian stocks fell last week as conflict escalated in the Middle East, an earthquake shook Japan in the final minutes of trading on Friday, and European debt concerns continued to resurface. The increasing death toll due to the earthquake-triggered tsunami and the potential nuclear disaster in Japan are currently major factors of concern
• The MSCI Asia Pacific Index fell 3.1% last week, its biggest drop since August. Nikkei 225 Stock Average fell 4.1% last week, Australia’s S&P/ASX 200 Index dropped 4.5%, Hong Kong’s Hang Seng Index slipped 0.7%, China’s Shanghai Composite Index lost 0.3%, and South Korea’s Kospi Index declined 2.5%
• International carriers, companies deriving significant amounts of sales from the Middle East, insurance companies, and mining companies were hardest hit
• The impact of the Japanese earthquake on the Japanese market was clearly evident on the corporate front. Toyota and Fanuc, Japan’s biggest maker of industrial robots, fell by 5% and 4.7% respectively
English英语译成Chinese汉语: ABC Company Investment Analytics General field: 商务/金融 Detailed field: 投资/证券
原文文本 - English英语 A successful example of our investment process is our implementation of a yield curve flattening trade in Europe during the past year. Over the course of the past few years, multiple countries in Europe have passed legislation instructing pension funds (and some insurance companies) to improve the means of capital preservation relative to their liabilities (asset-liability matching). As a result of this legislation, most pension funds need to extend the average duration of their assets. Our research concluded that in the next few years, there will be constant demand for the long-end of the European yield curve in bonds and swaps. Therefore, we believe that in a rising rate environment, there will be a ceiling on long term European rates, and in a falling rate environment, the concern of continual lower yields will force pension funds to buy at unattractive levels.
ABC analytics provide integrated automated transaction processing and risk management and supply valuable information to portfolio managers for their use in making investment decisions and calibrating risk positions. Their analyses enable portfolio managers to identify relative value between securities and to understand the impact of buy and sell decisions on a portfolio. Portfolio managers have on-line access to all analytical information and receive our risk management package daily (the Green Package), which provides detailed risk analysis of every portfolio under management. ABC’s state-of-the-art technology includes scenario horizon analysis, micro-analysis of derivative mortgage securities, option-adjusted spread analysis and duration/convexity analysis.
English英语译成Chinese汉语: Patient Informed Consent General field: 医学 Detailed field: 医疗：医药
原文文本 - English英语 A randomised, 4-week, placebo-controlled, double-blind, 6 arm parallel group, dose finding clinical trial, to assess the efficacy, safety and pharmacokinetics of three different doses of formoterol (6, 12 & 18 µg) combined with the inhaled anticholinergic aclidinium bromide 200µg, aclidinium bromide 200µg monotherapy, formoterol 12µg monotherapy and placebo all administered once daily by inhalation via ALMIRALL inhaler in patients with stable moderate to severe chronic obstructive pulmonary disease.
You are invited to participate in a research study of an investigational medication to treat moderate to severe Chronic Obstructive Pulmonary Disease (COPD). Before deciding to take part, it is very important for you to read carefully and fully understand the following information. This trial, protocol and Informed consent form have been approved by an Ethics Committee/Regulatory Authority and describes the purpose, procedures, benefits, discomforts, risks and precautions which may result from your participation in this research study. It also describes your right to refuse participation or to withdraw from the study at any time, without giving a reason. Please ask the study doctor or nurse any questions you have; they will be happy to answer them and explain things in more detail. Your participation is completely voluntary and will not have an impact on the quality of treatment that you will receive from your study doctor and his/ her staff, or from the hospital, or from any other medical facilities or providers. Take your time to decide whether or not you wish to take part in the study. If you decide to participate, you will be asked to sign this document to demonstrate your understanding of the study and its requirements, and you will be giving your study doctor your permission to enrol you into the study.
What is the study about?
Chronic Obstructive Pulmonary Disease (COPD) is a lung disease in which the lung is damaged, making it hard to breathe. In COPD, the airways/tubes that carry air in and out of your lungs are partly obstructed, making it difficult to get air in and out. COPD gets gradually worse over time. At the moment there is no cure for COPD. The best way to slow the disease is to quit smoking. Medications are used to alleviate shortness of breath and cough, and to treat infections of the lungs that can worsen COPD. The most important medications belong to a class of drugs called bronchodilators. Bronchodilators relax the muscles around the bronchi (tubes in the lungs) to allow easier breathing. There are two main kinds of inhaled bronchodilators. These include “beta-agonists” and “anticholinergics”. Both keep airways open and may decrease lung secretions. Because the two classes work by different mechanisms, they can be used together. Most of these bronchodilators are given in an inhaled form using a dry powder inhaler.
Almirall, a Spanish Pharmaceutical Company located in Barcelona, Spain, is developing a compound named aclidinium bromide. Aclidinium bromide is an anticholinergic bronchodilator whose effect lasts for at least 24 hours. Aclidinium bromide only needs to be taken once a day via an inhaler. Aclidinium bromide as a single form of inhaled treatment has been tested on 654 patients already, and further trials are ongoing.
翻译文本 - English英语 Best performers
• Want Want China (0151 HK): Want Want China reported on March 6 net incomes of $419 million for the year ended last December, up 17% from the previous year, beating market expectations. The company attributed the improvement in performance mainly to the growing demand for beverage and snacks. Gross margin in 2011, however, fell by 2.8 percentage points to 34.8%, pushed down by the rising material prices and labor costs. The hike in material prices is expected to have significant impact on the food industry, with Tingyi (0322 HK) falling nearly 5% YTD.
• Tencent Holdings (0700 HK): Tencent Holdings on March 14 released its annual report for 2011. The company booked a record revenue and profit of RMB28.496 billion and RMB10.2 billion, respectively, driven mainly by the increase in revenue from social network, online games and other core businesses. The company, however, recorded a net loss of RMB24.255 million from equity investments. President indicated that the company might decelerate its investment in 2012. Last year, Tencent Holdings launched the Tencent Collaboration Fund with an initial size of RMB5 billion, which was then boosted to RMB10 billion. The Fund mainly focuses on e-commerce, deal-of-the-day industry, online tourism, online video and social network.
Poor performers
• Sun Hung Kai Properties (00016 HK): On March 29, the co-chairmans of Sun Hung Kai Properties, Raymond Kwok and Thomas Kwok were arrested by the Independent Commission Against Corruption over alleged violation of the “Prevention of Bribery Ordiance” for an investigation. Previously, on March 19, an executive director Thomas Chan was detained on the same grounds. The company abruptly suspended the trading in its shares at 9:51 A.M. March 29, when the stock was trading at HK$111.30, and closed the day down 1.33%. The co-chairmans were released that night but the company’s stock had been badly hit. Sung Hung Kai Properties slumped by 13% on March 30, with most Hong Kong developers dragged down.
• China Life Insurance (2628 HK): China Life Insurance released on March 27 its results for 2011. Net income was RMB18.331 billion, representing a significant decrease of 45.5% from the previous year. In 2011, the company's investment assets were RMB1.49 trillion, up 11.9% YoY. The overall investment yield was 3.51%. The insurance industry was sluggish in 2011, with the big four insurers’ combined net income falling 20.77% from RMB61.744 in 2010 to RMB48.918 billion.
加入会员日期： Jan '11
positive
